choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Duloxetine

Duloxetine Newsletter
  • SSRIs and SNRIs Boost Clozapine Treatment Response 01 Aug 2025 12:03 GMT

    treatment-resistant schizophrenia, unlike other antidepressants, according to a new study. Sertraline, duloxetine … ranges for each medication. The primary … optimal for some drugs. Schizophrenia relapse … various sources including pharmaceutical companies. Details …

  • Addressing Pain in Oral Mucositis: Narrative Review of Current Practices and Emerging Treatments 23 Jul 2025 19:59 GMT

    … In these cases medications like duloxetine (an antidepressant) and gabapentin ( … In a clinical trial involving 275 patients, … receiving cancer treatment: evidence from randomised controlled trials. Curr … a treatment option for radiation-induced mucositis. Drug

  • Understanding anxiety: Symptoms, treatments, and medications 23 Jul 2025 18:55 GMT

    … anxiety disorders, explores popular medications used in treatment, and discusses effective … : Anxiety directly caused by drug use, medication, or withdrawal. Symptoms of … SNRIs) include: Venlafaxine (Effexor XR) Duloxetine (Cymbalta) SNRIs are also effective …

  • Summertime Warning: Oklahoma pharmacist highlights medication heat risks 18 Jul 2025 23:17 GMT

    … heat stroke, warn doctors at Integris Health. … fluoxetine, venlafaxine, and duloxetine, can impair your body … . Some antipsychotics/antidepressants (e.g., olanzapine, clozapine … counter products, including allergy medications, decongestants, pain relievers …

  • Antidepressant withdrawal is rare, study finds. Here are the most common symptoms 11 Jul 2025 10:12 GMT

    … controlled trials – which are considered the gold standard in medical research … (SNRIs) like venlafaxine and duloxetine. Researchers tracked the number of … placebos, or dummy treatments. Overall, patients who stopped antidepressants experienced one extra …

  • Doubt Cast on the Need for Long-Term Antidepressant Tapering 11 Jul 2025 07:55 GMT

    antidepressant treatment, noting that some patients hesitate to start medication … inhibitors such as paroxetine, duloxetine, sertraline, escitalopram, venlafaxine … close ties to drug manufacturers and … UCB Pharma, Janssen Pharmaceuticals and ADM. Domschke …

  • Most Antidepressant Users Don’t Face Severe Withdrawal 10 Jul 2025 16:26 GMT

    … studies. Drug-Specific Effects: Withdrawal severity varied by medication, … antidepressants, including the serotonin-norepinephrine reuptake inhibitors (SNRIs) venlafaxine and duloxetine … are common conditions and antidepressant treatments are effective and …

  • Results from largest review of its kind on antidepressant withdrawal symptoms   09 Jul 2025 16:04 GMT

    antidepressants, including the serotonin-norepinephrine reuptake inhibitors (SNRIs) venlafaxine and duloxetinedrugs.” In terms of study limitations, 38 of the trialstrial involving long-term antidepressant … conditions and antidepressant treatments are …

  • Antidepressants Can Cause Weight Gain. Help Patients Manage 08 Jul 2025 06:40 GMT

    … reasons patients stop taking antidepressants, or decline to start … Brintha Vasagar, MDShe noted that duloxetine (Cymbalta) and bupropion ( … in the doctor’s office vs pharmaceutical industry ads … choosing medications. “We can make adjustments in treatment if …

  • Spain orders famous antidepressant to be recalled after batch was found with ‘impurities’ 05 Jul 2025 20:19 GMT

    … de Medicamentos y Productos Sanitarios) has detected impurities within the drug Ludiomil … Cenexi, based in France, the drug is in high demand and … they can monitor the withdrawal. Duloxetine, another antidepressant, was also withdrawn in …

Satisfied with the content?

Continue to create your account.